En español



Quick Links

COVID-19 is an emerging, rapidly evolving situation.

Get the latest information from CDC (Coronavirus.gov) | NIH Resources | NIDA Resources

NIDA Notice of Special Interest (NOSI)

Revised January 2020

Formerly known as Drug Abuse Topics of Special/Continuing Interest (DAT)

Important: Please contact the Program Official/Contact(s) before submitting an application.

A Notice of Special Interest (NOSI) is a new format for NIH Institutes/Centers to share and update their research priorities. NOSIs are intended to replace Program Announcements (PAs) that do not have special review criteria or set aside funds. Each NOSI describes aims in a specific scientific area(s) and points to Funding Opportunity Announcements (FOAs) through which investigators can apply for support.

Note that we continue to encourage investigator-initiated projects in topic areas not listed here, and that applications submitted in response to the relevant funding opportunities are NOT limited to the research and development areas described below.

This website only lists scientific/research topics and contacts and instructions for linking applications to specific topics of interest to NIDA (NOSIs). What is not included are additional application instructions, eligibility restrictions, review criteria, selection criteria, or other items related to the completeness or compliance of an application. These are found in the SF424 application guide.

Instructions for Submitting Applications:

For funding consideration, applicants must include “NOT-XX-XXX” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered as responding to a NOSI.

Topic Code Contacts
Notice of Special Interest (NOSI): Biomarkers and Biotypes of Drug Addiction NOT-DA-20-012

Tanya Ramey, MD, Ph.D.
Phone: (301) 827-5944

Kristopher Bough, Ph.D.
Phone: (301) 442-9800

Notice of Special Interest (NOSI): Preclinical and Clinical Studies of the Interactions of Opioids and Stimulants NOT-DA-20-007

Nathan M. Appel, Ph.D.
Phone: (301) 827-5918

Katrina Foster, Ph.D.
Phone: (301) 827-5815

Holly Moore, Ph.D.
Phone: (301) 827-7376

Notice of Special Interest (NOSI): Epidemiology of Drug Abuse NOT-DA-19-066

Marsha Lopez, Ph.D., MHS
Phone: (301) 402-1846

Notice of Special Interest (NOSI): Public Health Research on Cannabis NOT-DA-19-065

Marsha Lopez, Ph.D., MHS
Phone: (301) 402-1846
Steve Gust, Ph.D.
Phone: (301) 402-1118
Heather Kimmel, Ph.D.
Phone: (301) 443-6504

Notice of Special Interest (NOSI): Research to Prevent Drug Use, Misuse and Addiction NOT-DA-19-048 Amy B. Goldstein, Ph.D.
Phone: (301) 827-4124
Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R01, R21, R03) NOT-DA-19-037 Tisha Wiley, Ph.D.
Phone: (301) 594-4381
Notice of Special Interest (NOSI): Gene-Environment Interplay in Substance Use Disorders (R01, R21) NOT-DA-19-038 Naimah Weinberg, M.D.
Phone: (301) 443-6504
Amy C. Lossie, Ph.D.
Phone: (301) 827-6092
Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research NOT-DA-19-041 Susan Wright, Ph.D.
Phone: (301) 402-6683
Basic Research on Opioids (R01, R03, R21) (PDF, 612KB) DAT18-07 Jonathan Pollock, Ph.D.
Neuroimmune Signaling and Function in Substance Use Disorders (R01, R21) (PDF, 543KB) DAT18-01 Roger G Sorensen, Ph.D., MPA
Effects of Cannabis Use and Cannabinoids on the Developing Brain (R01, R03, R21) (PDF, 568KB) DAT18-04 Da-Yu Wu, PhD
Karen Sirocco, Ph.D.
Effects of Opioids and their Antagonists on Fetal and Neonatal Brain Development (R01, R03, R21) (PDF, 353KB) DAT18-09 Ann L. Anderson, MD, MPH
Karen Sirocco, Ph.D.
Da-Yu Wu, Ph.D.

This page was last updated January 2020

Get this Publication

    Search for Funding

    2016-2020 NIDA Strategic Plan